Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Current Leases (2022 - 2025)

TransMedics has reported Current Leases over the past 4 years, most recently at $3.3 million for Q4 2025.

  • Quarterly results put Current Leases at $3.3 million for Q4 2025, up 21.38% from a year ago — trailing twelve months through Dec 2025 was $3.3 million (up 21.38% YoY), and the annual figure for FY2025 was $3.3 million, up 21.38%.
  • Current Leases for Q4 2025 was $3.3 million at TransMedics, up from $3.2 million in the prior quarter.
  • Over the last five years, Current Leases for TMDX hit a ceiling of $3.3 million in Q4 2025 and a floor of $1.3 million in Q1 2022.
  • Median Current Leases over the past 4 years was $2.1 million (2023), compared with a mean of $2.2 million.
  • Biggest five-year swings in Current Leases: increased 10.77% in 2023 and later surged 41.23% in 2025.
  • TransMedics' Current Leases stood at $1.4 million in 2022, then skyrocketed by 40.93% to $2.0 million in 2023, then skyrocketed by 34.0% to $2.7 million in 2024, then grew by 21.38% to $3.3 million in 2025.
  • The last three reported values for Current Leases were $3.3 million (Q4 2025), $3.2 million (Q3 2025), and $3.0 million (Q2 2025) per Business Quant data.